Help us understand experiences and improve pain management for injectable syphilis treatment

November 7, 2024:

Summary

Clinicians from the BC Centre for Disease Control (BCCDC) are conducting a brief survey for people who have had or are about to receive injectable syphilis treatment (bicillin).

The goal is to understand peoples’ experiences and pain to inform pain management strategies before and during injectable syphilis treatment.

Background & Objectives

Syphilis is a sexually transmitted infection (STI) caused by the bacteria Treponema pallidum. It is treated with antibiotics, usually offered as an injection of a long-acting penicillin (bicillin) into each hip or buttock muscle. Patients can sometimes experience pain or discomfort during or after the injection.

We are looking at ways to improve the experience of patients by developing pain management approaches to be shared with clinicians and patients.

Who can participate?

Anyone who has had or is about the receive injectable syphilis treatment (bicillin). The survey is available in English, Simplified Chinese, and Punjabi.

What can I do?

If you are someone who has had or about to receive injectable syphilis treatment, you can complete the survey by following this link.

If you are a clinician, you can help by offering this survey to patients receiving syphilis treatment or by using the image and QR code below to promote it the survey in your clinic.

About the survey

The survey should only take about 5 minutes to complete. You do not need to share any personally identifiable information unless you want to be entered into a monthly gift card draw for participation. The information you share is always kept private and confidential.

Participation in this survey will directly inform the development of resources and strategies to improve pain management for injectable syphilis treatment (bicillin). Thank you in advance for participating or sharing this survey within your networks.

Source link

tags

Abkhazia Afghanistan Africa Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Costa Rica Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France French Polynesia Gabon Gambia Georgia Germany Ghana Greece Grenada Guam Guatemala Guinea Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Madagascar Malawi Malaysia Maldives Mali Malta Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nepal Netherlands New Zealand Nicaragua Niger Nigeria North Korea North Macedonia Northern Cyprus Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Republic of the Congo Romania Russia Rwanda Saint Lucia Samoa San Marino Saudi Arabia Senegal Serbia Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Korea South Sudan Spain Sri Lanka Sudan Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Uganda UK Ukraine United Arab Emirates Uruguay USA Uzbekistan Vatican City Venezuela Vietnam Western Sahara Yemen Zambia Zimbabwe